Albumin-Based MUC13 Peptide Nanomedicine Suppresses Liver Cancer Stem Cells via JNK-ERK Signaling Pathway-Mediated Autophagy Inhibition
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c06034 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Fen Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an 271016, China. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Autophagy, Liver Neoplasms, MAP Kinase Signaling System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Taishan Scholar Project of Shandong Province, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an 271016, China.
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China.
- School of Life Sciences, Tsinghua University, Beijing 100084, China.
- State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
- Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, China.
- School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.
ORCID-Profile: Changlong Wang
Förderung
- Taishan Scholar Project of Shandong Province
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Youth Innovation Team Program of Colleges and Universities in Shandong Province
- Talent Introduction Project of Shandong First Medical University
Zitieren
APA
Sun, F., Ding, Z., Shao, F., Gao, X., Tian, H., Zhang, X., Chen, H., & Wang, C. (2024). Albumin-Based MUC13 Peptide Nanomedicine Suppresses Liver Cancer Stem Cells via JNK-ERK Signaling Pathway-Mediated Autophagy Inhibition. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c06034
Vancouver
Sun F, Ding Z, Shao F, Gao X, Tian H, Zhang X, et al. Albumin-Based MUC13 Peptide Nanomedicine Suppresses Liver Cancer Stem Cells via JNK-ERK Signaling Pathway-Mediated Autophagy Inhibition. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c06034
BibTeX
@article{Sun2024,
author = {Sun, Fen and Ding, Zongyao and Shao, Fengying and Gao, Xiaoyang and Tian, Haina and Zhang, Xiao and Chen, Huaqing and Wang, Changlong},
title = {Albumin-Based MUC13 Peptide Nanomedicine Suppresses Liver Cancer Stem Cells via JNK-ERK Signaling Pathway-Mediated Autophagy Inhibition},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c06034}
}
EUVIMED